Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 203 Pages
Report ld: 4867713
Request Sample
Customized Report
The global Antiviral and Antibacterial Textiles market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
From a downstream perspective, Daily Necessity accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Antiviral and Antibacterial Textiles leading manufacturers including Foss Manufacturing, Acordis, Fuji, Trevira GmbH, Sotexpro, Toray, BioCote, Milliken & Company, UNITIKA, PurThread Technologies, etc., dominate supply; the top five capture approximately % of global revenue, with Foss Manufacturing leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Antiviral and Antibacterial Textiles market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Antiviral and Antibacterial Textiles study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Antiviral and Antibacterial Textiles: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Antiviral and Antibacterial Textiles Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Inorganic
1.2.3 Organic
1.3 Market Segmentation by Application
1.3.1 Global Antiviral and Antibacterial Textiles Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Daily Necessity
1.3.3 Clothing
1.3.4 Medical
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Antiviral and Antibacterial Textiles Revenue Estimates and Forecasts 2020-2031
2.2 Global Antiviral and Antibacterial Textiles Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Antiviral and Antibacterial Textiles Sales Estimates and Forecasts 2020-2031
2.4 Global Antiviral and Antibacterial Textiles Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Antiviral and Antibacterial Textiles Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Antiviral and Antibacterial Textiles Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Antiviral and Antibacterial Textiles Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Inorganic Market Size by Manufacturers
4.5.2 Organic Market Size by Manufacturers
4.6 Global Antiviral and Antibacterial Textiles Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Antiviral and Antibacterial Textiles Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Antiviral and Antibacterial Textiles Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Antiviral and Antibacterial Textiles Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Antiviral and Antibacterial Textiles Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
7.4 North America Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Antiviral and Antibacterial Textiles Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
8.4 Europe Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Antiviral and Antibacterial Textiles Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Antiviral and Antibacterial Textiles Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
10.4 Central and South America Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Antiviral and Antibacterial Textiles Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Antiviral and Antibacterial Textiles Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Antiviral and Antibacterial Textiles Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Antiviral and Antibacterial Textiles Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Foss Manufacturing
12.1.1 Foss Manufacturing Corporation Information
12.1.2 Foss Manufacturing Business Overview
12.1.3 Foss Manufacturing Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.1.4 Foss Manufacturing Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Product in 2024
12.1.6 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Application in 2024
12.1.7 Foss Manufacturing Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.1.8 Foss Manufacturing Antiviral and Antibacterial Textiles SWOT Analysis
12.1.9 Foss Manufacturing Recent Developments
12.2 Acordis
12.2.1 Acordis Corporation Information
12.2.2 Acordis Business Overview
12.2.3 Acordis Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.2.4 Acordis Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Acordis Antiviral and Antibacterial Textiles Sales by Product in 2024
12.2.6 Acordis Antiviral and Antibacterial Textiles Sales by Application in 2024
12.2.7 Acordis Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.2.8 Acordis Antiviral and Antibacterial Textiles SWOT Analysis
12.2.9 Acordis Recent Developments
12.3 Fuji
12.3.1 Fuji Corporation Information
12.3.2 Fuji Business Overview
12.3.3 Fuji Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.3.4 Fuji Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Fuji Antiviral and Antibacterial Textiles Sales by Product in 2024
12.3.6 Fuji Antiviral and Antibacterial Textiles Sales by Application in 2024
12.3.7 Fuji Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.3.8 Fuji Antiviral and Antibacterial Textiles SWOT Analysis
12.3.9 Fuji Recent Developments
12.4 Trevira GmbH
12.4.1 Trevira GmbH Corporation Information
12.4.2 Trevira GmbH Business Overview
12.4.3 Trevira GmbH Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.4.4 Trevira GmbH Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Product in 2024
12.4.6 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Application in 2024
12.4.7 Trevira GmbH Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.4.8 Trevira GmbH Antiviral and Antibacterial Textiles SWOT Analysis
12.4.9 Trevira GmbH Recent Developments
12.5 Sotexpro
12.5.1 Sotexpro Corporation Information
12.5.2 Sotexpro Business Overview
12.5.3 Sotexpro Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.5.4 Sotexpro Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Sotexpro Antiviral and Antibacterial Textiles Sales by Product in 2024
12.5.6 Sotexpro Antiviral and Antibacterial Textiles Sales by Application in 2024
12.5.7 Sotexpro Antiviral and Antibacterial Textiles Sales by Geographic Area in 2024
12.5.8 Sotexpro Antiviral and Antibacterial Textiles SWOT Analysis
12.5.9 Sotexpro Recent Developments
12.6 Toray
12.6.1 Toray Corporation Information
12.6.2 Toray Business Overview
12.6.3 Toray Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.6.4 Toray Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Toray Recent Developments
12.7 BioCote
12.7.1 BioCote Corporation Information
12.7.2 BioCote Business Overview
12.7.3 BioCote Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.7.4 BioCote Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 BioCote Recent Developments
12.8 Milliken & Company
12.8.1 Milliken & Company Corporation Information
12.8.2 Milliken & Company Business Overview
12.8.3 Milliken & Company Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.8.4 Milliken & Company Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Milliken & Company Recent Developments
12.9 UNITIKA
12.9.1 UNITIKA Corporation Information
12.9.2 UNITIKA Business Overview
12.9.3 UNITIKA Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.9.4 UNITIKA Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 UNITIKA Recent Developments
12.10 PurThread Technologies
12.10.1 PurThread Technologies Corporation Information
12.10.2 PurThread Technologies Business Overview
12.10.3 PurThread Technologies Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.10.4 PurThread Technologies Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 PurThread Technologies Recent Developments
12.11 NBC Meshtec
12.11.1 NBC Meshtec Corporation Information
12.11.2 NBC Meshtec Business Overview
12.11.3 NBC Meshtec Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.11.4 NBC Meshtec Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 NBC Meshtec Recent Developments
12.12 Microban
12.12.1 Microban Corporation Information
12.12.2 Microban Business Overview
12.12.3 Microban Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.12.4 Microban Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Microban Recent Developments
12.13 Sanitized AG
12.13.1 Sanitized AG Corporation Information
12.13.2 Sanitized AG Business Overview
12.13.3 Sanitized AG Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.13.4 Sanitized AG Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Sanitized AG Recent Developments
12.14 Noble Biomaterials
12.14.1 Noble Biomaterials Corporation Information
12.14.2 Noble Biomaterials Business Overview
12.14.3 Noble Biomaterials Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.14.4 Noble Biomaterials Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 Noble Biomaterials Recent Developments
12.15 HeiQ Materials AG
12.15.1 HeiQ Materials AG Corporation Information
12.15.2 HeiQ Materials AG Business Overview
12.15.3 HeiQ Materials AG Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.15.4 HeiQ Materials AG Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 HeiQ Materials AG Recent Developments
12.16 Teijin
12.16.1 Teijin Corporation Information
12.16.2 Teijin Business Overview
12.16.3 Teijin Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.16.4 Teijin Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 Teijin Recent Developments
12.17 Nippon Shokubai
12.17.1 Nippon Shokubai Corporation Information
12.17.2 Nippon Shokubai Business Overview
12.17.3 Nippon Shokubai Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.17.4 Nippon Shokubai Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 Nippon Shokubai Recent Developments
12.18 BASF
12.18.1 BASF Corporation Information
12.18.2 BASF Business Overview
12.18.3 BASF Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.18.4 BASF Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 BASF Recent Developments
12.19 Murata
12.19.1 Murata Corporation Information
12.19.2 Murata Business Overview
12.19.3 Murata Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.19.4 Murata Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 Murata Recent Developments
12.20 Dow
12.20.1 Dow Corporation Information
12.20.2 Dow Business Overview
12.20.3 Dow Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.20.4 Dow Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Dow Recent Developments
12.21 ANNIL
12.21.1 ANNIL Corporation Information
12.21.2 ANNIL Business Overview
12.21.3 ANNIL Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.21.4 ANNIL Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 ANNIL Recent Developments
12.22 Bioserica Era
12.22.1 Bioserica Era Corporation Information
12.22.2 Bioserica Era Business Overview
12.22.3 Bioserica Era Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.22.4 Bioserica Era Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 Bioserica Era Recent Developments
12.23 Qianhai Guangda
12.23.1 Qianhai Guangda Corporation Information
12.23.2 Qianhai Guangda Business Overview
12.23.3 Qianhai Guangda Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.23.4 Qianhai Guangda Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.5 Qianhai Guangda Recent Developments
12.24 Ruyi Woolen Garment Group
12.24.1 Ruyi Woolen Garment Group Corporation Information
12.24.2 Ruyi Woolen Garment Group Business Overview
12.24.3 Ruyi Woolen Garment Group Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.24.4 Ruyi Woolen Garment Group Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.24.5 Ruyi Woolen Garment Group Recent Developments
12.25 Jiangsu Jonnyma New Materials
12.25.1 Jiangsu Jonnyma New Materials Corporation Information
12.25.2 Jiangsu Jonnyma New Materials Business Overview
12.25.3 Jiangsu Jonnyma New Materials Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.25.4 Jiangsu Jonnyma New Materials Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.25.5 Jiangsu Jonnyma New Materials Recent Developments
12.26 Zhong Wang Fabric
12.26.1 Zhong Wang Fabric Corporation Information
12.26.2 Zhong Wang Fabric Business Overview
12.26.3 Zhong Wang Fabric Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.26.4 Zhong Wang Fabric Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.26.5 Zhong Wang Fabric Recent Developments
12.27 Taihua New Material
12.27.1 Taihua New Material Corporation Information
12.27.2 Taihua New Material Business Overview
12.27.3 Taihua New Material Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.27.4 Taihua New Material Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.27.5 Taihua New Material Recent Developments
12.28 Lu Thai Textile
12.28.1 Lu Thai Textile Corporation Information
12.28.2 Lu Thai Textile Business Overview
12.28.3 Lu Thai Textile Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.28.4 Lu Thai Textile Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.28.5 Lu Thai Textile Recent Developments
12.29 Fynex Textile
12.29.1 Fynex Textile Corporation Information
12.29.2 Fynex Textile Business Overview
12.29.3 Fynex Textile Antiviral and Antibacterial Textiles Product Models, Descriptions and Specifications
12.29.4 Fynex Textile Antiviral and Antibacterial Textiles Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.29.5 Fynex Textile Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Antiviral and Antibacterial Textiles Industry Chain
13.2 Antiviral and Antibacterial Textiles Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Antiviral and Antibacterial Textiles Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Antiviral and Antibacterial Textiles Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Antiviral and Antibacterial Textiles Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Antiviral and Antibacterial Textiles Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Antiviral and Antibacterial Textiles market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 217
USD 4900.00
(Single User License)
The global Antiviral and Antibacterial Textiles market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 124
USD 4250.00
(Single User License)
The global market for Antiviral and Antibacterial Textiles was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 190
USD 3950.00
(Single User License)
The global Antiviral and Antibacterial Textiles market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 172
USD 2900.00
(Single User License)
The global market for Antiviral and Antibacterial Textiles was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 171
USD 3950.00
(Single User License)
The global Antiviral and Antibacterial Textiles market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 123
USD 4250.00
(Single User License)
The global market for Antiviral and Antibacterial Textiles was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 133
USD 2900.00
(Single User License)
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
Published Date: 2024-09-04
Pages: 135
USD 2900.00
(Single User License)
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
Published Date: 2024-09-04
Pages: 200
USD 4350.00
(Single User License)
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
Published Date: 2024-09-04
Pages: 203
USD 4900.00
(Single User License)
The global Antiviral and Antibacterial Textiles market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 217
The global Antiviral and Antibacterial Textiles market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 124
The global market for Antiviral and Antibacterial Textiles was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 190
The global Antiviral and Antibacterial Textiles market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 172
The global market for Antiviral and Antibacterial Textiles was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 171
The global Antiviral and Antibacterial Textiles market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 123
The global market for Antiviral and Antibacterial Textiles was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 133
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
Published: 2024-09-04
Pages: 135
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
Published: 2024-09-04
Pages: 200
Antiviral and antimicrobial textiles refer to textiles that have been specially treated or made from special materials, designed to reduce or inhibit the survival and spread of bacteria and viruses on the fabric surface. These textiles are widely used in various fields such as medical applications, personal protective equipment, everyday clothing, and household items.
Published: 2024-09-04
Pages: 203
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now